NIH TITLE

FOA

Org

Expires

Activity Code

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program: Phase 2 Clinical Trials (UG3/UH3 Clinical Trial Required)

RFA-AR-19-029

NIAMS

Feb 26, 2019

UG3/UH3

HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Methodology and Advanced Analytics Resource Center (U2C Clinical Trial Not Allowed)

RFA-DA-19-023

NIDA

Feb 27, 2019

U2C

HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (U01 Clinical Trial Optional)

RFA-HL-19-029

NHLBI

Feb 27, 2019

U01

HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Coordination and Translation Center (U2C Clinical Trial Optional)

RFA-DA-19-024

NIDA

Feb 27, 2019

U2C

HEAL Initiative: Sleep and Circadian-Dependent Mechanisms Contributing to Opiate Use Disorder (OUD) and Response to Medication Assisted Treatment (MAT) (R01 – Clinical Trial Not Allowed)

RFA-HL-19-028

NHLBI

Feb 27, 2019

R01

HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Clinical Research Centers (UG1 Clinical Trial Optional)

RFA-DA-19-025

NIDA

Feb 27, 2019

UG1

Promoting Research on Music and Health: Fundamentals and Applications (R21 Clinical Trials Optional)

RFA-NS-19-009

NINDS

Feb 28, 2019

R21

Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)

RFA-AT-19-001

NCCIH

Feb 28, 2019

R61/R33

Promoting Research on Music and Health: Fundamentals and Applications (R01 Clinical Trials Optional)

RFA-NS-19-008

NINDS

Feb 28, 2019

R01

HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed)

RFA-TR-19-003

NCATS

Feb 28, 2019

UG3/UH3

HEAL Initiative: Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and Overdose for Drug Screening (UH2/UH3 Clinical Trial Not Allowed)

RFA-TR-19-005

NCATS

Feb 28, 2019

UH2/UH3

Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Not Allowed)

RFA-NS-19-010

NINDS

Mar 6, 2019

UG3/UH3

HEAL Initiative: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain – (U44 Clinical Trial Not Allowed)

RFA-NS-19-020

NINDS

Mar 6, 2019

U44

HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) Initiative (U24 Clinical Trial Not Allowed)

RFA-DA-19-034

NIDA

Mar 13, 2019

U24

HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) (UG3/UH3 Clinical Trial Required)

RFA-DA-19-035

NIDA

Mar 13, 2019

UG3/UH3

HEAL Initiative Limited Competition: Behavioral Research to Improve MAT: Ancillary Studies to Enhance Behavioral or Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R01, Clinical Trials Optional)

RFA-AT-19-007

NCCIH

Mar 15, 2019

R01

Heal Initiative: Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3 Clinical Trial Required)

RFA-AT-19-005

NCCIH

Mar 15, 2019

UG3/UH3

Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R01 Clinical Trial Optional)

RFA-AT-19-008

NCCIH

Mar 15, 2019

R01

Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R21 Clinical Trial Optional)

RFA-AT-19-009

NCCIH

Mar 15, 2019

R21

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program: Mechanistic Research Centers (U19 Clinical Trial Optional)

RFA-AR-19-026

NIAMS

Mar 20, 2019

U19

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center (U24 Clinical Trial Not Allowed)

RFA-AR-19-027

NIAMS

Mar 20, 2019

U24

HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Technology Research Sites (UH2/UH3 Clinical Trial Optional)

RFA-AR-19-028

NIAMS

Mar 20, 2019

UH2/UH3

Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/R42 – Clinical Trial Optional)

RFA-DA-19-032

NIDA

Mar 20, 2019

R41/R42

Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R43/R44 – Clinical Trial Optional)

RFA-DA-19-033

NIDA

Mar 20, 2019

R43/R44

HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34- Clinical Trial Not Allowed)

RFA-DA-19-029

NIDA

Mar 25, 2019

R34

HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) ( R34- Clinical Trial Not Allowed)

RFA-DA-19-036

NIDA

Mar 25, 2019

R34

HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium – Clinical Centers (U01 Clinical Trial Required)

RFA-DK-18-030

NIDDK

Mar 27, 2019

U01

HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium – Scientific and Data Research Center (U01 Clinical Trial Required)

RFA-DK-18-031

NIDDK

Mar 27, 2019

U01

HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium (PL1 Clinical Trials Not Allowed)

RFA-HD-19-025

NICHD

Mar 29, 2019

PL1

Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18)

RFA-HS-19-001

AHRQ

Mar 31, 2019

R18

HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trial Required)

RFA-MH-19-525

NIMH

Apr 1, 2019

U01

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

PA-18-574

NIH

Apr 5, 2019

R43/R44

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

PA-18-575

NIH

Apr 5, 2019

R41/R42

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)

PA-18-576

NIH

Apr 5, 2019

R41/R42

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

PA-18-573

NIH

Apr 5, 2019

R43/R44

Prescription Drug Abuse (R01 Clinical Trial Optional)

PA-18-058

NIDA

May 7, 2019

R01

Prescription Drug Abuse (R21 Clinical Trial Optional)

PA-18-076

NIDA

May 7, 2019

R21

Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional)

PA-18-141

NINR

May 7, 2019

R01

Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional)

PA-18-159

NINR

May 7, 2019

R21

Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed)

RFA-HD-19-024

NICHD

May 14, 2019

R01

Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial Not Allowed)

PAR-18-331

NIMHD

Jun 7, 2019

R01

Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01)

PAR-17-484

NIMHD

Dec 4, 2019

R01

Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R21)

PAR-17-483

NIMHD

Dec 4, 2019

R21

Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)

RFA-DA-19-002

NIDA

Jan 1, 2020

UG3/UH3

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01 Clinical Trial Optional)

PA-18-038

NICHD

Jan 7, 2020

R01

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)

PA-18-043

NICHD

Jan 7, 2020

R21

Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional)

PA-18-044

NICHD

Jan 7, 2020

R03

Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional)

PA-18-060

NIDA

Jan 7, 2020

R01

Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)

PA-18-078

NIDA

Jan 7, 2020

R21

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)

PAR-18-662

NCCIH

Feb 28, 2020

UG3/UH3

NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)

PAR-18-118

NCCIH

Feb 29, 2020

U01

Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)

RFA-NS-18-041

NINDS

Mar 12, 2020

R61/R33

Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)

RFA-NS-18-046

NINDS

Mar 12, 2020

R61/R33

Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R21)

PA-17-157

NIDA

May 7, 2020

R21

Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R01)

PA-17-155

NIDA

May 7, 2020

R01

Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01 Clinical Trial Optional)

PA-18-061

NIDA

May 7, 2020

R01

Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21 Clinical Trial Optional)

PA-18-079

NIDA

May 7, 2020

R21

Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03 Clinical Trial Optional)

PA-18-080

NIDA

May 7, 2020

R03

Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional)

RFA-DA-19-003

NIDA

Jul 17, 2020

R61/R33

Assay development and screening for discovery of chemical probes or therapeutic agents (R01)

PAR-17-438

NCI

Sep 7, 2020

R01

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 – Clinical Trials Required)

PAR-18-417

NCCIH

Sep 7, 2020

R34

Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional)

PAS-18-624

NIDA

Sep 7, 2020

R01

Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional)

PAS-18-625

NIDA

Sep 7, 2020

R21

Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)

PAR-18-745

NIMHD

Nov 13, 2020

R21

Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)

PAR-18-747

NIMHD

Nov 13, 2020

R01

NINDS Exploratory Clinical Trials for Small Business (R44) – Clinical Trial Required

PAR-18-618

NINDS

Jan 5, 2021

R44

NINDS Exploratory Clinical Trials for Small Business (R42) – Clinical Trial Required

PAR-18-617

NINDS

Jan 5, 2021

R42

Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial Optional)

PA-18-775

NIDA

Jan 7, 2021

R34

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp – Clinical Trial Optional)

PA-18-591

NIH

Jan 25, 2021

(Admin Supp)

Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional)

PAR-18-742

NIDA

Feb 11, 2021

R61/R33

HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)

RFA-NS-19-016

NINDS

Feb 22, 2021

UG3/UH3

HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)

RFA-NS-19-017

NINDS

Feb 22, 2021

U44

HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)

RFA-NS-19-018

NINDS

Feb 22, 2021

UH3

HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)

RFA-EB-18-003

NIBIB

Feb 22, 2021

U18

Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 – Clinical Trial Optional)

PAR-18-506

NICHD

May 7, 2021

R01

Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed)

PA-18-660

NIAAA

May 7, 2021

R01

Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R03 Clinical Trial Optional)

PA-18-687

NICHD

May 7, 2021

R03

Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01 Clinical Trial Optional)

PA-18-688

NICHD

May 7, 2021

R01

International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional)

PA-18-773

NIDA

May 7, 2021

R01

Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34 – Clinical Trial Optional)

PA-18-780

NIDA

May 7, 2021

R34

HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional)

PAS-18-915

NIDA

Sep 7, 2021

R01

Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 – Clinical Trial Optional)

PA-18-917

NIDA

Sep 7, 2021

R01

HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 – Clinical Trial Optional)

RFA-DA-19-019

NIDA

Sep 8, 2021

R43/R44

HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 – Clinical Trial Optional)

RFA-DA-19-020

NIDA

Sep 8, 2021

R41/R42

Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)

PAR-19-039

NINDS

Sep 14, 2021

U01

Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)

PAR-19-040

NINDS

Sep 14, 2021

U01

Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)

PAR-19-064

NIDA

Nov 8, 2021

R21

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)

PAR-19-100

NCATS

Nov 9, 2021

R21

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional)

PAR-19-099

NCATS

Nov 9, 2021

U01

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

PA-18-932

ODP

Jan 7, 2022

R01

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional)

PA-18-946

NINR

Jan 7, 2022

R21

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional)

PA-18-945

NINR

Jan 7, 2022

R01

Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional)

PA-18-943

NINR

Jan 7, 2022

R21

Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional)

PA-18-944

NINR

Jan 7, 2022

R01

End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional)

PAR-19-045

NINR

Jan 7, 2022

R01

End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional)

PAR-19-044

NINR

Jan 7, 2022

R21